StockData
VOGXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Vogenx, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 17, 2026
$15.92+1.39 (+9.57%)

Close on Oct 19, 2026

Market cap
$86.79M
P/E (TTM)
–
Dividend yield
–

Ownership

Who owns Vogenx's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
JANUS HENDERSON GROUP Ltd.1,923,07613.00%13G (passive)Aug 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Steven R. DelmarChief Financial Officer, Director704,2734.74%Aug 13, 2026
James GreenChief Executive Officer, Director, 10% owner1,800,00012.12%Aug 11, 2026
William WilkisonChief Scientific Officer, Director, 10% owner1,800,00012.12%Aug 11, 2026
Kenneth John ToombsDirector––Sep 28, 2026
Peter PieracciniDirector42,7350.29%Aug 13, 2026
Timothy BorisDirector––Aug 11, 2026
Richard M. GormanDirector––Aug 11, 2026
Investments I. LLC Osprey10% owner––Aug 11, 2026
Wowig, Llc10% owner––Aug 11, 2026
Richard Bentley Cheatham10% owner700,0004.71%Aug 11, 2026
Lynn Anne Cheatham10% owner––Aug 11, 2026
Stanhope-1, LLC10% owner––Aug 11, 2026
Melissa Green10% owner––Aug 11, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Peter Pieraccini
Director
Aug 13, 2026Conversion+42,735$11.70$500.00K42,735
Steven R. Delmar
Chief Financial Officer, Director
Aug 13, 2026Conversion+4,273$11.70$49.99K704,273

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.